Dallen Medical Announces First in Man Use of Its Compressyn™ Staple for Small Bone Fixation

SAN CLEMENTE, Calif.--()--Dallen Medical, Inc., an innovator in bone fixation and repair, today announced the first human use of its Compressyn™ Staple, the only rigid compression fixation technology that delivers continual, dynamic compression for small bone fixation.

The first procedure was a treatment for an arthritic foot, where the Compressyn staple was used to perform the calcaneal cuboid fusion of a triple arthrodesis. FDA-cleared in February 2013, the Compressyn Staple is designed for a broad range of foot, ankle and hand fixation, including Jones fracture, Lisfranc dislocations, metatarsal fractures or bunionectomies.

“Our next generation staple system improves upon the drawbacks of nitinol and other stainless steel staples to deliver more consistent, dynamic compression designed to improve patient outcomes,” said Dallen Medical Chief Executive Officer David Mills. “This first in man milestone demonstrates that we are continuing to execute well as a company, with a strong track record of regulatory and clinical success.”

The proprietary, stainless steel Compressyn Staple springs into position upon delivery, providing active tension that creates strong, consistent compression. The Compressyn Staple is more rigid than nitinol staples, minimizing the risk of splaying and improving patient outcomes, which may reduce treatment costs and length of hospital stay. The unique staple design also virtually eliminates distraction, which has been an issue with competitive stainless steel staples.

The Compressyn Staple can be delivered either with its affordable disposable delivery system, which provides one-step staple delivery and compression, or its reusable delivery system.

About Dallen Medical, Inc.

Dallen Medical is an early-stage orthopedic company whose patented technology provides superior fixation and compression. The Company has seven FDA clearances around its Compressyn™ and Tensyn™ technologies and is targeting underserved markets where it can deliver a higher standard of fixation without compromising speed or ease of use. For more information, visit www.dallenmedical.com.

Contacts

Chronic Communications
Michelle McAdam, 310-902-1274
michelle@chronic-comm.com

Release Summary

Dallen Medical announces the first in man use of its proprietary Compressyn Staple for small bone fixation using continuous, dynamic compression.

Contacts

Chronic Communications
Michelle McAdam, 310-902-1274
michelle@chronic-comm.com